Bleeding in women with venous thromboembolism during pregnancy: A systematic review of the literature
- PMID: 36051542
- PMCID: PMC9424506
- DOI: 10.1002/rth2.12801
Bleeding in women with venous thromboembolism during pregnancy: A systematic review of the literature
Abstract
Objectives: Venous thromboembolism (VTE) represents an important cause of maternal morbidity and mortality. Estimates of bleeding associated with therapeutic-dose anticoagulation are variable. We describe the frequency of bleeding in pregnant women receiving therapeutic anticoagulation for VTE by means of a systematic review of the literature.
Data sources: Medical Literature Analysis and Retrieval System, Embase, Scopus, Web of Science, and ClinicalTrials.gov were searched. Databases were searched from inception to February 27, 2022. There was no language or geographic location restriction.
Methods of study selection: The search yielded 2773 articles with 2212 unique citations. Studies were included if they described pregnant women treated for an acute VTE with therapeutic-dose anticoagulation and a defined bleeding outcome was reported.
Tabulation integration and results: Five studies met inclusion criteria. Included studies were judged to have a serious to critical risk of bias using the Risk of Bias in Nonrandomized Studies of Intervention tool. The rate of bleeding, as defined by respective studies, ranged between 2.9% and 30.0%. Two studies included control groups, one of which found no significant difference in the risk of bleeding between groups, while the other found a significantly increased bleeding risk associated with therapeutic anticoagulation.
Conclusion: Among pregnant women anticoagulated for VTE, the reported bleeding risk is variable. The ability to draw definite conclusions is limited by the scarcity and low quality of the studies, the small number of included patients, and the heterogeneity of bleeding definitions used. Large-scale studies with standardized bleeding definitions are required to provide acute bleeding estimates and optimize the care of these patients.
Systematic review registration: PROSPERO, CRD42021276771.
Keywords: anticoagulation; hemorrhage; pregnancy; venous thromboembolism.
© 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH).
Figures
Similar articles
-
Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.Cochrane Database Syst Rev. 2020 Oct 10;10(10):CD013399. doi: 10.1002/14651858.CD013399.pub2. Cochrane Database Syst Rev. 2020. PMID: 33038027 Free PMC article.
-
Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register.Ther Adv Drug Saf. 2021 Dec 16;12:20420986211062965. doi: 10.1177/20420986211062965. eCollection 2021. Ther Adv Drug Saf. 2021. PMID: 34987749 Free PMC article.
-
Effect of anticoagulation on the incidence of venous thromboembolism, major bleeding, and mortality among hospitalized COVID-19 patients: an updated meta-analysis.Front Cardiovasc Med. 2024 Apr 5;11:1381408. doi: 10.3389/fcvm.2024.1381408. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38646150 Free PMC article.
-
Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol.Syst Rev. 2019 Oct 28;8(1):245. doi: 10.1186/s13643-019-1175-5. Syst Rev. 2019. PMID: 31661033 Free PMC article.
-
Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review.BMJ Open. 2021 Jul 29;11(7):e045672. doi: 10.1136/bmjopen-2020-045672. BMJ Open. 2021. PMID: 34326045 Free PMC article.
Cited by
-
Prevention, diagnosis, and management of PE and DVT in pregnant women.Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):237-247. doi: 10.1182/hematology.2023000476. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066865 Free PMC article. Review.
-
Preemptive anticoagulation during antenatal pulmonary embolism diagnostics in a community setting: retrospective cohort study.Res Pract Thromb Haemost. 2025 Jan 31;9(1):102695. doi: 10.1016/j.rpth.2025.102695. eCollection 2025 Jan. Res Pract Thromb Haemost. 2025. PMID: 40104811 Free PMC article.
-
Successful Conservative Treatment of Maternal Spontaneous Unilateral Adrenal Hemorrhage Causing Severe Anemia in the Third Trimester of Pregnancy-A Case Report.Medicina (Kaunas). 2024 Sep 4;60(9):1448. doi: 10.3390/medicina60091448. Medicina (Kaunas). 2024. PMID: 39336489 Free PMC article.
-
Standardizing definitions for bleeding events in studies including pregnant women: A call to action.Res Pract Thromb Haemost. 2022 Oct 25;6(7):e12822. doi: 10.1002/rth2.12822. eCollection 2022 Oct. Res Pract Thromb Haemost. 2022. PMID: 36313985 Free PMC article. No abstract available.
References
-
- Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. N Engl J Med. 2008;359(19):2025‐2033. - PubMed
-
- Bailly J, Jacobson BF, Louw S. Safety and efficacy of adjusted‐dose enoxaparin in pregnant patients with increased risk for venous thromboembolic disease. Int J Gynaecol Obstet. 2019;145(1):70‐75. - PubMed
-
- James AH. Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol. 2009;29(3):326‐331. - PubMed
-
- Chan WS, Rey E, Kent NE, et al. Venous thromboembolism and antithrombotic therapy in pregnancy. J Obstet Gynaecol Can. 2014;36(6):527‐553. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous